Lara Heckmann

Ms. Lara Heckmann

University Hospital Frankfurt

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2021 in Cells
Verified
Journal Article
Open access
PDF file
APAlex Palumbo
Alex Palumbo
PGPhilipp Grüning
Philipp Grüning
SLSvenja Kim Landt
Svenja Kim Landt
LHLara Heckmann
Lara Heckmann
LBLuisa Bartram
Luisa Bartram
Marietta ZilleMarietta Zille
Marietta Zille
Axonal degeneration (AxD) is a pathological hallmark of many neurodegenerative diseases. Deciphering the morphological patterns of AxD will help to understand the underlying mechanisms and develop effective therapies. Here, we evaluated the progression of AxD in cortical neurons using a novel microfluidic device together with a deep learning tool that we developed for the enhanced-throughput analysis of AxD on microscopic images. The trained convolutional neural network (CNN) sensitively and specifically segmented the features of AxD including axons, axonal swellings, and axonal fragments. Its performance exceeded that of the human evaluators. In an in vitro model of AxD in hemorrhagic stroke induced by the hemolysis product hemin, we detected a time-dependent degeneration of axons leading to a decrease in axon area, while axonal swelling and fragment areas increased. Axonal swellings preceded axon fragmentation, suggesting that swellings may be reliable predictors of AxD. Using a recurrent neural network (RNN), we identified four morphological patterns of AxD (granular, retraction, swelling, and transport degeneration). These findings indicate a morphological heterogeneity of AxD in hemorrhagic stroke. Our EntireAxon platform enables the systematic analysis of axons and AxD in time-lapse microscopy and unravels a so-far unknown intricacy in which AxD can occur in a disease context.

6 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
AMAnanthakrishnan Vijayakumar Maya
Ananthakrishnan Vijayakumar Maya
LNLena Neuhaus
Lena Neuhaus
LNLiyne Nogay
Liyne Nogay
ASAakriti Singh
Aakriti Singh
LHLara Heckmann
Lara Heckmann
ACAnne-Kathrin Classen
Anne-Kathrin Classen
Inflammation triggers systemic growth restrictions, a process well characterised in tumour cachexia. Whether inflammatory tissue damage also induces growth restrictions, and how regenerating tissue overcome them, is less explored. Using a tissue damage model in Drosophila , we identify metabolic and signaling adaptations that both induce and bypass systemic growth restrictions. Expression of eiger , the Drosophila TNF-α homolog, in imaginal discs causes systemic insulin restriction and insulin resistance, reducing protein translation and proliferation in peripheral tissues. Regenerating cells overcome this by upregulating Pdk1, which is necessary and sufficient to promote protein translation via an Insulin/Akt-independent mechanism. JAK/STAT acts upstream to elevate Pdk1, defining a JAK/STAT-Pdk1-S6K axis essential for regenerative proliferation. Regenerating cells also upregulate amino acid transporters and rely on mTORC1. Similar signatures in Ras V12 , scrib tumors indicate that tumors co-opt these pathways to sustain growth under insulin restriction. This physiological program thus integrates systemic nutrient mobilization and local metabolic reprogramming, with implications for tissue repair but also pathologies, such as chronic wounds and cancer.

21 February 2021
Verified
Book Chapter
Closed access
PDF file
PGPhilipp Grüning
Philipp Grüning
APAlex Palumbo
Alex Palumbo
SLSvenja Kim Landt
Svenja Kim Landt
LHLara Heckmann
Lara Heckmann
LBLeslie Brackhagen
Leslie Brackhagen
Amir Madany MamloukAmir Madany Mamlouk
Amir Madany Mamlouk

27 August 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
APAlex Palumbo
Alex Palumbo
PGPhilipp Grüning
Philipp Grüning
SLSvenja Kim Landt
Svenja Kim Landt
LHLara Heckmann
Lara Heckmann
LBLuisa Bartram
Luisa Bartram
Marietta ZilleMarietta Zille
Marietta Zille
Background: Axonal degeneration (AxD) is a pathological hallmark of many neurodegenerative diseases. Deciphering the morphological patterns of AxD will help to understand the underlying mechanisms and to develop effective therapeutic interventions. Here, we evaluated the progression of AxD in cortical neurons using a novel microfluidic device in combination with a deep learning tool, the EntireAxon, that we developed for the enhanced-throughput analysis of AxD on microscopic images. Results: The EntireAxon convolutional neural network sensitively and specifically segmented the features of AxD, including axons, axonal swellings, and axonal fragments, and its performance exceeded that of human expert raters. In an in vitro model of AxD in hemorrhagic stroke induced by the hemolysis product hemin, we detected the concentration- and time-dependent degeneration of axons leading to a decrease in axon area, while the axonal swelling and axonal fragment area increased. Time course analysis revealed that axonal swellings preceded axon fragmentation, suggesting that swellings may be reliable predictors of AxD. Using a recurrent neural network, we further identified four morphological patterns of AxD (granular, retraction, swelling, and transport degeneration) in cortical axons subjected to hemin. Conclusions: These findings indicate a morphological heterogeneity of AxD under pathophysiologic conditions. The combination of the microfluidic device with the EntireAxon deep learning tool enable the systematic analysis of AxD but also unravel a so far unknown intricacy in which AxD can occur in a disease context.